Huntington National Bank Trims Stake in Humana Inc. (NYSE:HUM)

Huntington National Bank decreased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 16.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,249 shares of the insurance provider's stock after selling 1,210 shares during the quarter. Huntington National Bank's holdings in Humana were worth $1,585,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Public Sector Pension Investment Board grew its holdings in Humana by 13.0% during the third quarter. Public Sector Pension Investment Board now owns 5,222 shares of the insurance provider's stock worth $1,654,000 after buying an additional 600 shares in the last quarter. Paloma Partners Management Co lifted its position in shares of Humana by 33.7% during the third quarter. Paloma Partners Management Co now owns 853 shares of the insurance provider's stock valued at $270,000 after purchasing an additional 215 shares in the last quarter. HighTower Advisors LLC lifted its position in shares of Humana by 2.1% during the 3rd quarter. HighTower Advisors LLC now owns 8,992 shares of the insurance provider's stock worth $2,852,000 after buying an additional 187 shares in the last quarter. Investment Management Corp of Ontario boosted its stake in shares of Humana by 42.9% in the 3rd quarter. Investment Management Corp of Ontario now owns 3,996 shares of the insurance provider's stock worth $1,266,000 after buying an additional 1,200 shares during the last quarter. Finally, IHT Wealth Management LLC grew its holdings in shares of Humana by 38.2% in the third quarter. IHT Wealth Management LLC now owns 1,082 shares of the insurance provider's stock valued at $334,000 after acquiring an additional 299 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Guggenheim began coverage on shares of Humana in a report on Wednesday. They issued a "buy" rating and a $326.00 price target on the stock. StockNews.com raised Humana from a "hold" rating to a "buy" rating in a research report on Monday. Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Seventeen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $284.25.

Humana Price Performance

Shares of NYSE HUM traded up $3.35 during midday trading on Wednesday, hitting $285.30. 2,653,232 shares of the company's stock were exchanged, compared to its average volume of 1,743,722. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The business's fifty day moving average price is $265.60 and its two-hundred day moving average price is $270.92. The company has a market cap of $34.43 billion, a price-to-earnings ratio of 28.67, a PEG ratio of 2.05 and a beta of 0.62. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.24%. Humana's dividend payout ratio (DPR) is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.